Press releases

BioStock: Sprint Bioscience receives research grant

October 25, 2021 | Non Regulatory Press Release

BioStock: Sprint Bioscience initiates marketing of the DISA-program

September 29, 2021 | Non Regulatory Press Release

Sprint Bioscience initiates marketing of an additional cancer drug program

September 27, 2021 | Non Regulatory Press Release

BioStock: A new cancer project in Sprint Bioscience’s portfolio

September 9, 2021 | Non Regulatory Press Release

Sprint Bioscience adds new cancer drug program to its project portfolio

September 8, 2021 | Non Regulatory Press Release

Sprint Bioscience licenses the cancer drug program Vps34 to Deciphera Pharmaceuticals

August 3, 2021 | Regulatory Press Release

BioStock: Sprint Bioscience’s new CEO on the business model and cancer projects

April 29, 2021 | Non Regulatory Press Release

BioStock: Directed issue of 20.7 MSEK strengthens cash position for Sprint Bioscience

April 8, 2021 | Non Regulatory Press Release

BioStock: Great interest in Sprint Bioscience at BIO-Europe

April 1, 2021 | Non Regulatory Press Release

Sprint Bioscience appoints Erik Kinnman as new CEO

February 26, 2021 | Regulatory Press Release